Peer Review reports
From: Trastuzumab immunogenicity development in patients’ sera and in laboratory animals
| Original Submission | ||
|---|---|---|
| 5 Nov 2020 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 4 Dec 2020 | Reviewed | Reviewer Report |
| 17 Dec 2020 | Reviewed | Reviewer Report - Atul Agrawal |
| 9 Jan 2021 | Author responded | Author comments - Mohammad Aboulwafa |
| Resubmission - Version 3 | ||
| 9 Jan 2021 | Submitted | Manuscript version 3 |
| 11 Jan 2021 | Author responded | Author comments - Mohammad Aboulwafa |
| Resubmission - Version 4 | ||
| 11 Jan 2021 | Submitted | Manuscript version 4 |
| 20 Jan 2021 | Reviewed | Reviewer Report |
| 31 Jan 2021 | Reviewed | Reviewer Report - Atul Agrawal |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 3 Feb 2021 | Editorially accepted | |
| 19 Feb 2021 | Article published | 10.1186/s12865-021-00405-z |
You can find further information about peer review here.